Anpario (LON:ANP) Reaches New 52-Week High – Here’s What Happened

Anpario plc (LON:ANP)’s share price reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 474 ($5.98) and last traded at GBX 474 ($5.98), with a volume of 110170 shares. The stock had previously closed at GBX 452.50 ($5.71).

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lifted their target price on Anpario from GBX 380 ($4.79) to GBX 500 ($6.31) and gave the stock a “buy” rating in a report on Tuesday, January 14th.

Anpario Price Performance

The company has a debt-to-equity ratio of 0.10, a current ratio of 6.15 and a quick ratio of 5.16. The stock has a market cap of £80.87 million, a price-to-earnings ratio of 26.17 and a beta of 0.58. The stock has a fifty day moving average of GBX 412.84 and a 200 day moving average of GBX 346.

Insider Buying and Selling

In related news, insider Karen Prior sold 14,000 shares of Anpario stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.79), for a total transaction of £53,200 ($67,112.40). Corporate insiders own 30.51% of the company’s stock.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.